Overview

Dose-Escalation Safety and Pharmacokinetic Study of K305

Status:
Completed
Trial end date:
2010-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the pharmacokinetics/pharmacodynamics and safety of a nasal spray containing the anesthetic drug tetracaine in combination with oxymetazoline
Phase:
Phase 2
Details
Lead Sponsor:
St. Renatus, LLC
Collaborators:
Ground Zero Pharmaceuticals
Rho, Inc.
Treatments:
Oxymetazoline
Phenylephrine
Tetracaine